Why the study?
Does nifedipine reduce blood pressure and improve symptoms in patients with refractory hypertension and heart failure with preserved systolic function?
Does nifedipine reduce blood pressure and improve symptoms in patients with refractory hypertension and heart failure with preserved systolic function?
Nifedipine safely and effectively reduces blood pressure and improves symptoms in patients with severe hypertension and heart failure with preserved systolic function.
Answers are grounded in this paper and cite their sources.
Case report data do not support practice change; leaves open nifedipine role in refractory hypertension with preserved EF.
Nifedipine was used successfully in nine patients with refractory hypertension and left ventricular hypertrophy who had symptoms of congestive heart failure despite preserved left ventricular systolic function. The administration of 10 or 20 mg of nifedipine resulted in an acute decline in BP, from 211 +/- 8/105 +/- 6 mm Hg to 153 +/- 9/78 +/- 5 mm Hg. Six patients received nifedipine and one patient received long-term verapamil therapy (mean follow-up, 16 +/- 4 weeks). In addition to sustained BP control, signs and symptoms of congestive heart failure were greatly improved in all patients treated long term with calcium channel antagonists. No adverse reactions were reported, but a short duration of action limited their usefulness in some patients. Nifedipine seems to be particularly beneficial in this subgroup of severe hypertensive patients with heart failure presumably due to diastolic stiffness of the left ventricle.
No takes yet. Share an insight, caveat, or question.
Bruce D. Given (1985) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: